Copper Peptide AHK-Cu vs Hexapeptide-9
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Tripeptide-3, Ala-His-Lys Copper
AHK-Cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. It is the lesser-known sibling of the naturally occurring GHK-Cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. It is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study.
Also: Collaxyl, Collaxyl IS
Hexapeptide-9 is a collagen-inspired signaling peptide sold as Collaxyl (originally from Vincience, now Ashland) for anti-wrinkle and firming skincare. The idea is that a small repeat of a collagen sequence nudges skin cells to rebuild the junction between the outer and inner skin. It is a cosmetic ingredient, and the evidence for the original peptide is mostly old, small and company-run, although a 2025 trial on a modified cyclic version is more interesting.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Copper Peptide AHK-Cu | Hexapeptide-9 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Copper peptides like AHK-Cu are thought to act as carriers and signals for copper, a metal involved in tissue repair, blood vessel growth and collagen remodeling. In hair, the proposed action centers on dermal papilla cells, the control hub at the base of each follicle that orchestrates the growth cycle. AHK-Cu is hypothesized to keep those cells alive and dividing longer, partly by shifting the balance of survival proteins (more Bcl-2, less Bax) so follicle cells are less likely to enter programmed cell death, which would extend the active growth phase. These are mechanisms observed in cells and isolated follicles, not proven outcomes in people growing hair. | Hexapeptide-9 is Gly-Pro-Gln-Gly-Pro-Gln, a repeat taken from collagen sequences. Ashland says the sequence is found in collagen IV and XVII and works as a matrikine, a matrix fragment that signals cells to make more matrix proteins. The claimed targets are the dermal-epidermal junction (collagen IV, laminin-5, integrins) and collagen production. The original patent describes it as designed to improve cell adhesion and possibly support matrix production. One weakness is stability: the linear peptide is easily broken down by collagen-digesting enzymes, which is why a Chinese group built a ring-shaped (cyclized) version to make it last longer in skin. |
| Common Dosing | Limited community data available See research protocols | Low single-digit percent of the ingredient in a finished product Once or twice daily |
| Administration | Topical (scalp serums, solutions) | Topical (serums, creams) |
| Typical Duration | 3-6 months for visible results | 4-8 weeks in studies; ongoing use to maintain any effect |
| Best Time to Take | Morning or as directed | Morning and/or evening, on clean skin |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The science here is real but narrow. The anchor study is Pyo and colleagues, published in Archives of Pharmacal Research in 2007, which tested AHK-Cu on human hair follicles and dermal papilla cells outside the body. At very low concentrations it significantly lengthened isolated human hair follicles and increased dermal papilla cell proliferation, while reducing apoptosis markers, and notably the effect followed a tight dose-response curve where higher concentrations stopped working. That is genuine peer-reviewed evidence for a biological effect. What does not exist is the part people actually want: randomized controlled human trials showing that applying AHK-Cu to a scalp regrows hair or thickens it in living people. So the honest read is that AHK-Cu has a plausible mechanism and one credible ex vivo and in vitro study behind it, but its real-world hair-growth benefit in humans is unproven, and most consumer claims extrapolate well beyond what that single study supports. | The oldest human data is a 2004 study from Vincience, the lab behind Collaxyl: a double-blind, placebo-controlled test of a gel containing 3% of a 'collagen-like hexapeptide' plus a 1% booster ingredient, applied around the eyes of 20 women for four weeks. It reported fewer and shallower wrinkles on skin replicas, but the booster and the small size mean it cannot prove the peptide alone did the work. Supplier material cites other 28-day studies in about 20 volunteers that we could not trace to journals. The newest and best-designed study is a 2025 randomized, double-blind trial in the Journal of Cosmetic Dermatology (96 adults aged 30-55 in China) comparing a cyclized hexapeptide-9 serum at 0.002% with 0.002% retinol and a vehicle for 56 days. The cyclized peptide beat both on wrinkle, elasticity and hydration measures, with no treatment-related side effects. Two caveats: it tested a modified molecule, not the Collaxyl peptide in most products, and several authors are affiliated with cosmetic companies. Bottom line: the concept has some support, the cyclic version looks promising, but regular hexapeptide-9 in a store-bought cream rests on thin evidence. |
Frequently Asked Questions: Copper Peptide AHK-Cu vs Hexapeptide-9
What is the difference between Copper Peptide AHK-Cu and Hexapeptide-9?
Copper Peptide AHK-Cu is a skin & hair peptide that ahk-cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. it is the lesser-known sibling of the naturally occurring ghk-cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. it is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study. Hexapeptide-9 is a skin & hair peptide that hexapeptide-9 is a collagen-inspired signaling peptide sold as collaxyl (originally from vincience, now ashland) for anti-wrinkle and firming skincare. the idea is that a small repeat of a collagen sequence nudges skin cells to rebuild the junction between the outer and inner skin. it is a cosmetic ingredient, and the evidence for the original peptide is mostly old, small and company-run, although a 2025 trial on a modified cyclic version is more interesting. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Copper Peptide AHK-Cu or Hexapeptide-9?
Neither is universally "better" - the choice depends on your specific goals. Copper Peptide AHK-Cu is typically used for skin & hair purposes, while Hexapeptide-9 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Copper Peptide AHK-Cu and Hexapeptide-9 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Copper Peptide AHK-Cu and Hexapeptide-9 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.